Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

127 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Clinical utility of genomic DNA Q-PCR for the monitoring of a patient with atypical e19a2 BCR-ABL1 transcripts in chronic myeloid leukemia.
Pagani IS, Dang P, Saunders VA, Braley J, Thieleke A, Branford S, Hughes TP, Ross DM. Pagani IS, et al. Among authors: saunders va. Leuk Lymphoma. 2020 Oct;61(10):2527-2529. doi: 10.1080/10428194.2020.1772476. Epub 2020 Jun 6. Leuk Lymphoma. 2020. PMID: 32508223 No abstract available.
Lineage of measurable residual disease in patients with chronic myeloid leukemia in treatment-free remission.
Pagani IS, Dang P, Saunders VA, Grose R, Shanmuganathan N, Kok CH, Carne L, Rwodzi Z, Watts S, McLean J, Braley J, Altamura H, Yeung DT, Branford S, Yong ASM, White DL, Hughes TP, Ross DM. Pagani IS, et al. Among authors: saunders va. Leukemia. 2020 Apr;34(4):1052-1061. doi: 10.1038/s41375-019-0647-x. Epub 2019 Nov 25. Leukemia. 2020. PMID: 31768016
╬▓arrestin-1 regulates DNA repair by acting as an E3-ubiquitin ligase adaptor for 53BP1.
Nieto A, Hara MR, Quereda V, Grant W, Saunders V, Xiao K, McDonald PH, Duckett DR. Nieto A, et al. Among authors: saunders v. Cell Death Differ. 2020 Apr;27(4):1200-1213. doi: 10.1038/s41418-019-0406-6. Epub 2019 Sep 10. Cell Death Differ. 2020. PMID: 31506606 Free PMC article.
Gene expression signature that predicts early molecular response failure in chronic-phase CML patients on frontline imatinib.
Kok CH, Yeung DT, Lu L, Watkins DB, Leclercq TM, Dang P, Saunders VA, Reynolds J, White DL, Hughes TP. Kok CH, et al. Among authors: saunders va. Blood Adv. 2019 May 28;3(10):1610-1621. doi: 10.1182/bloodadvances.2019000195. Blood Adv. 2019. PMID: 31126916 Free PMC article.
Lenalidomide maintenance treatment after imatinib discontinuation: results of a phase 1 clinical trial in chronic myeloid leukaemia.
Ross DM, Pagani IS, Irani YD, Clarson J, Leclercq T, Dang P, McLean J, Saunders VA, Carne L, Reynolds J, Ritchie DS, White DL, Branford S, Hughes TP, Yong ASM. Ross DM, et al. Among authors: saunders va. Br J Haematol. 2019 Aug;186(3):e56-e60. doi: 10.1111/bjh.15894. Epub 2019 Mar 27. Br J Haematol. 2019. PMID: 30916385 Clinical Trial. No abstract available.
Expression and localisation of thymosin beta-4 in the developing human early fetal heart.
Saunders V, Dewing JM, Sanchez-Elsner T, Wilson DI. Saunders V, et al. PLoS One. 2018 Nov 9;13(11):e0207248. doi: 10.1371/journal.pone.0207248. eCollection 2018. PLoS One. 2018. PMID: 30412598 Free PMC article.
Modelling ponatinib resistance in tyrosine kinase inhibitor-naïve and dasatinib resistant BCR-ABL1+ cell lines.
Lu L, Kok CH, Saunders VA, Wang J, McLean JA, Hughes TP, White DL. Lu L, et al. Among authors: saunders va. Oncotarget. 2018 Oct 5;9(78):34735-34747. doi: 10.18632/oncotarget.26187. eCollection 2018 Oct 5. Oncotarget. 2018. PMID: 30410673 Free PMC article.
Validation and Factor Analysis of the Child and Youth Resilience Measure for Indigenous Australian Boarding School Students.
Langham E, McCalman J, Redman-MacLaren M, Hunter E, Wenitong M, Britton A, Rutherford K, Saunders V, Ungar M, Bainbridge R. Langham E, et al. Among authors: saunders v. Front Public Health. 2018 Oct 23;6:299. doi: 10.3389/fpubh.2018.00299. eCollection 2018. Front Public Health. 2018. PMID: 30406069 Free PMC article.
Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cells.
Ross DM, Pagani IS, Shanmuganathan N, Kok CH, Seymour JF, Mills AK, Filshie RJ, Arthur CK, Dang P, Saunders VA, Braley J, Yong AS, Yeung DT, White DL, Grigg AP, Schwarer AP, Branford S, Hughes TP; Australasian Leukaemia and Lymphoma Group (ALLG). Ross DM, et al. Among authors: saunders va. Leukemia. 2018 Dec;32(12):2572-2579. doi: 10.1038/s41375-018-0264-0. Epub 2018 Oct 12. Leukemia. 2018. PMID: 30315232
A Community-Directed Integrated Strongyloides Control Program in Queensland, Australia.
Miller A, Young EL, Tye V, Cody R, Muscat M, Saunders V, Smith ML, Judd JA, Speare R. Miller A, et al. Among authors: saunders v. Trop Med Infect Dis. 2018 May 4;3(2):48. doi: 10.3390/tropicalmed3020048. Trop Med Infect Dis. 2018. PMID: 30274444 Free PMC article. Review.
127 results
Jump to page
Feedback